GSK has decided to pay $2 billion in cash to acquire Canadian-based medicine dev...
Biotech firm Moderna has released comprehensive data from mid-stage research on ...
Eli Lilly’s mirikizumab, an IL-23 inhibitor, has recently been rejected by the F...
Illumina has entered into a joint agreement with Henry Ford Health to analyze th...
Noah Medical, a Silicon Valley-based robotic lung surgery company, has raised $1...
This week we take a look at Moderna’s less than ideal flu vaccine trial results,...
Candesant Biomedical’s adhesive patch for heavy underarm perspiration has been a...
Moderna has stated that the company’s first-ever seasonal flu vaccine has not me...
NewYork-based healthcare company Crystal Run has been reportedly purchased by Un...
Evernorth, a subsidiary of the healthcare company Cigna, has recently launched a...
After filing for bankruptcy last December, Clovis Oncology found a tentative buy...
Pharmaceutical company AstraZeneca has revealed that a Phase 3 clinical trial of...
After the 3rd U.S. Circuit Court of Appeals in Philadelphia called out Johnson &...
C2N Diagnostics introduced its second-generation liquid biopsy technology to det...
An effective respiratory syncytial virus vaccination is now available for use af...
After an FDA rejection and a failed collaboration, Akebia Therapeutics is contin...
